Aftab Ala

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 993 citations · Full text

Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites

Aftab Ala, Carmen Stanca, Moueen Bu-Ghanim et al. · Hepatology · 2006 · 226 citations

Wilson disease in septuagenarian siblings

Aftab Ala, Jimo Borjigin, Arnold Rochwarger et al. · Hepatology · 2005 · 209 citations

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 162 citations

Translational Medicine, Pharmacology, Bis-choline Tetrathiomolybdate +3